S&P Futures
4,146.75 0.00 (0.00%) Dow Futures
32,768.00 +11.00 (+0.03%) Nasdaq Futures
13,242.00 +13.25 (+0.10%) Russell 2000 Futures
1,921.90 +0.10 (+0.01%) Crude Oil
89.24 +0.23 (+0.26%) Gold
1,788.40 -2.80 (-0.16%)
Yield10 Bioscience, Inc. (YTEN)
Chart Events
Performance Outlook
| Previous Close | 2.4300 |
| Open | 2.5500 |
| Bid | 0.0000 x 4000 |
| Ask | 0.0000 x 2200 |
| Day's Range | 2.4550 - 2.6100 |
| 52 Week Range | 1.9100 - 8.7600 |
| Volume | |
| Avg. Volume | 86,014 |
| Market Cap | 12.498M |
| Beta (5Y Monthly) | 1.55 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.4180 |
| Earnings Date | Aug 10, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.25 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for YTEN
Related Research
- Yield10 Bioscience, Inc.Analyst Report: Charles River Laboratories International, Inc.Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company’s research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.RatingFair ValueEconomic Moat5 days agoMorningstar
- GlobeNewswire
Yield10 Bioscience to Announce Second Quarter 2022 Financial Results and Host a Conference Call on Wednesday, August 10, 2022
WOBURN, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its second quarter 2022 financial results and provide a corporate update on Wednesday, August 10, 2022. Management will host a conference call on Wednesday, August 10, 2022 at 4:30 p.m. ET to review financial results, share corporate highlights, and provide an overall business update. Following manag
- GlobeNewswire
Yield10 Bioscience Changes the Name of its Canadian Subsidiary to Yield10 Oilseeds Inc.
WOBURN, Mass. and SASKATOON, Saskatchewan, July 12, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10 Bioscience” or the “Company”), an agricultural bioscience company, today announced the name change of its wholly-owned Canadian subsidiary to Yield10 Oilseeds Inc. from Metabolix Oilseeds, Inc. effective July 12, 2022. This name change creates an alignment of Yield10 Bioscience’s Canadian subsidiary with the branding associated with the Yield10 Bioscience business, which
- Zacks
Zacks Industry Outlook Highlights Archer Daniels Midland, Corteva, Yield10 Bioscience, Adecoagro and Calavo Grower
Archer Daniels Midland, Corteva, Yield10 Bioscience, Adecoagro and Calavo Grower have been highlighted in this Industry Outlook article.
